Literature DB >> 16457967

Who attends skin cancer clinics within a randomized melanoma screening program?

Philippa H Youl1, Monika Janda, Mark Elwood, John B Lowe, Ian T Ring, Joanne F Aitken.   

Abstract

BACKGROUND: Screening may reduce morbidity and mortality associated with melanoma, although in the absence of randomized-controlled trials, this remains unproven.
METHODS: As part of a randomized community-based trial of melanoma screening in Queensland, Australia, sociodemographic characteristics, skin cancer risk factors and attitudes towards skin cancer associated with attendance at screening clinics and reasons for attendance or non-attendance were examined. A telephone survey was conducted among 743 attendees and 298 non-attendees.
RESULTS: After adjustment, the following factors were associated with clinic attendance: age 40-49 years, having fair skin, a personal history of skin cancer or melanoma or concern about a specific spot or mole, and no recent whole-body skin examination by a doctor. The main reasons for attendance were "to see if I have melanoma", "to have a suspicious mole checked" or "to have a whole-body skin examination". The main reasons for non-attendance were lack of knowledge about the clinics, no time or being away while the clinics were held and having had a skin check in the recent past. Overall, 77% of non-attendees compared to 65% of attendees stated they planned to participate in future screening.
CONCLUSIONS: The results suggest that we were able to attract both men and women equally to a skin screening clinic, along with those at all levels of education and indicate the importance of using well-designed promotional materials to attract community members to skin screening clinics. Future work should test strategies to remove barriers to participation in skin screening identified in this study.

Entities:  

Mesh:

Year:  2006        PMID: 16457967     DOI: 10.1016/j.cdp.2005.10.003

Source DB:  PubMed          Journal:  Cancer Detect Prev        ISSN: 0361-090X


  3 in total

1.  Screening for reducing morbidity and mortality in malignant melanoma.

Authors:  Minna Johansson; John Brodersen; Peter C Gøtzsche; Karsten Juhl Jørgensen
Journal:  Cochrane Database Syst Rev       Date:  2019-06-03

2.  A systematic review and synthesis of qualitative and quantitative studies evaluating provider, patient, and health care system-related barriers to diagnostic skin cancer examinations.

Authors:  Maleka Najmi; Ashley E Brown; Sarah R Harrington; David Farris; Sarah Sepulveda; Kelly C Nelson
Journal:  Arch Dermatol Res       Date:  2021-04-28       Impact factor: 3.017

3.  'Mind your Moles' study: protocol of a prospective cohort study of melanocytic naevi.

Authors:  Uyen Koh; Monika Janda; Joanne F Aitken; David L Duffy; Scott Menzies; Richard A Sturm; Helmut Schaider; Brigid Betz-Stablein; Tarl Prow; H Peter Soyer; Adele C Green
Journal:  BMJ Open       Date:  2018-09-19       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.